Growth Metrics

bioAffinity Technologies (BIAF) Retained Earnings (2022 - 2025)

Historic Retained Earnings for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$65.4 million.

  • bioAffinity Technologies' Retained Earnings fell 2902.68% to -$65.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.4 million, marking a year-over-year decrease of 2902.68%. This contributed to the annual value of -$53.6 million for FY2024, which is 2026.66% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Retained Earnings is -$65.4 million, which was down 2902.68% from -$60.4 million recorded in Q2 2025.
  • bioAffinity Technologies' Retained Earnings' 5-year high stood at -$35.0 million during Q3 2022, with a 5-year trough of -$65.4 million in Q3 2025.
  • Moreover, its 4-year median value for Retained Earnings was -$46.6 million (2024), whereas its average is -$47.6 million.
  • As far as peak fluctuations go, bioAffinity Technologies' Retained Earnings tumbled by 2005.31% in 2024, and later tumbled by 2902.68% in 2025.
  • bioAffinity Technologies' Retained Earnings (Quarter) stood at -$36.7 million in 2022, then decreased by 21.65% to -$44.6 million in 2023, then dropped by 20.27% to -$53.6 million in 2024, then dropped by 21.95% to -$65.4 million in 2025.
  • Its Retained Earnings was -$65.4 million in Q3 2025, compared to -$60.4 million in Q2 2025 and -$56.3 million in Q1 2025.